Knight Therapeutics Inc. announced that Samira Sakhia will assume the role of President, effective September 1, 2021. Ms. Sakhia currently serves as Knight's President and Chief Operating Officer. Jonathan Ross Goodman will assume the role of Executive Chairman and will help direct Knight's strategy through his role as Executive Chairman of the Board and by providing the full benefit of his 27 years of experience, leadership and guidance. At 17.2% ownership, Jonathan remains Knight's largest shareholder. Also effective September 1, 2021, James Gale will transition to the role of lead director. Jim has been Chair of Knight's Board since founding on February 28th, 2014.